The CFAP300 gene helps assemble the tiny moving hairs called cilia that clear mucus from the airways and support sperm movement. This gene plays an important role in keeping that motion coordinated, so if it does not work properly, cilia may move weakly or not at all. People with harmful variants in the CFAP300 gene can have primary ciliary dyskinesia, which may cause a daily wet cough, repeated sinus or chest infections, ear problems, and fertility issues in some people.
What is a gene?
Genes are stretches of DNA that carry instructions cells use to make molecules or manage activities in the body. Some genes provide the directions for producing proteins, which are the functional parts of cells. Others are mainly involved in regulating when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can also influence how you respond to food, stress, or medicines. For a deeper look at this subject, you can find more information in the LearnHub.
Overview
CFAP300Gene function
What if the gene works
The CFAP300 gene helps build moving cilia and sperm tails. These tiny hairlike structures help clear mucus from the airways and support sperm movement.
Risk
What if the gene does not work
Changes in the CFAP300 gene can cause primary ciliary dyskinesia, with ongoing sinus and chest infections, sometimes unusual organ placement, and reduced fertility. Milder and more severe variants can influence which features appear and how strongly they affect breathing.
Treatment
What does that mean for your treatment
No CFAP300-specific treatment or drug choice is currently established for pathogenic variants in the CFAP300 gene. Care is guided by the person’s symptoms and standard management for the related condition, rather than by a targeted medicine for this gene.
Conditions associated with CFAP300
Gene function
What if the gene works
Many cells use tiny hairlike structures called motile cilia to move mucus and fluid in a steady direction. If you carry the CFAP300 gene, it helps your cells build and place the motor parts these cilia need to beat smoothly. This is also part of the system that supports the swimming movement of sperm tails.
One of the roles of the CFAP300 gene is to help cells prepare dynein arms (tiny motor parts) for motile cilia. These parts provide the force that lets cilia bend and beat.
CFAP300 also helps guide these motor parts into the cilium, the hairlike structure that does the moving. Correct placement supports an even, coordinated beat.
By supporting cilia motors, the CFAP300 gene helps tiny hairlike cilia that move mucus and fluid across the surfaces they line. The same core job supports movement in sperm tails.
What is a variant?
Within a gene, a genetic variant is a small change in its DNA sequence. These changes are common and help account for normal differences among people, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CFAP300 gene can disrupt the handling and delivery of dynein arm parts, the motor units that let cilia and sperm tails beat. More severe variants often leave little or no working CFAP300 protein, so cilia may lack many of these motors, while milder variants may preserve some assembly and movement; this is how CFAP300 gene variants affect cilia function. In people with primary ciliary dyskinesia, stronger loss of function can be linked to earlier or more marked features.
How variants are linked to conditions
Pathogenic variants in the CFAP300 gene cause primary ciliary dyskinesia, a genetic condition linked to ongoing sinus and chest infections, chronic wet cough, and ear problems from early life. Some people also have organs arranged differently in the chest or abdomen, known as laterality differences, and some men may have reduced fertility because sperm movement can be affected. In this setting, CFAP300 gene variants linked to primary ciliary dyskinesia can confirm the diagnosis rather than simply suggest higher risk.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are widely found in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, one specific well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CFAP300 gene. For many living with a disease-causing CFAP300 change, risk is mainly shaped by the inherited gene change itself rather than lifestyle or environmental factors, and a doctor or genetic counselor can help explain personal risk.
Inheritance of CFAP300 variants
CFAP300-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one variant in the CFAP300 gene from each parent. Parents who each carry one CFAP300 variant are often healthy themselves, and with each pregnancy there is a 25% chance the child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. In practical terms, how CFAP300 variants are inherited usually involves carrier parents passing the gene change to sons and daughters equally.
What does my CFAP300 result mean for my family?
For families with a disease-causing change in the CFAP300 gene, the pattern is usually recessive, which means close relatives may also carry the same gene change without having symptoms. Brothers and sisters could be affected or could be carriers, and other blood relatives may also want to learn whether they carry it. This can matter for family planning, especially if both parents are carriers.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for the CFAP300 gene is the main way to find out about variants in this gene. A lab usually reads the gene from a blood sample, saliva, or cheek swab and reports whether a variant was found, including whether it is known to be disease causing, likely benign, or still unclear.
When should I consider getting a genetic test?
Consider genetic testing for the CFAP300 gene if there are signs of an inherited condition that affects the tiny hair-like cleaners in the airways, called primary ciliary dyskinesia. Clues include a chronic wet cough from childhood, frequent sinus or ear infections, trouble clearing mucus, or a family history of the condition.
A genetic result is only one part of your health story
Genetic results can provide useful information, but how much they explain depends on the condition and on the kind of variant involved. How your body functions over time is also shaped by factors like age, lifestyle, environment, and medical history. In some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and makes the most sense when viewed alongside the rest of your care. In other situations, it may give a clear answer. For medication response, genetic results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. Because of this, the same medication may work better for some people, have less effect in others, or cause more side effects in people who are more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that focuses on how differences in genes affect responses to medicines. It examines connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medications, genes can influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more personalized. More on this topic is available in the LearnHub.
Drugs influenced by the CFAP300 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so general health concerns, treatment questions, or medication side effects are best discussed with your doctor or pharmacist.
History
The CFAP300 gene first appeared in human gene catalogs under the earlier name C11orf70, during the period when many newly identified genes were being mapped and named by their chromosome location rather than by a known role. In recent decades, awareness of this gene’s role has grown. Research in the late 2010s connected variants in the CFAP300 gene with primary ciliary dyskinesia, helping move it from a little known entry in gene databases to a clinically relevant gene. As evidence accumulated, the name CFAP300 was adopted to better reflect its link to cilia associated proteins. This shift in naming and recognition mirrors a broader change in genetics, where many genes first discovered on maps later gained clearer medical meaning.